Gaois

Search direction

Search mode

Filter results

Collections

49 results in 44 documents

  1. #2122450

    Na meastacháin i leith an ghéarnochta is airde, léiríonn siad géarnochtadh atá gar don ghéardháileog thagartha.

    The highest acute exposure estimates indicate an acute exposure close to the acute reference dose.

    Commission Regulation (EU) 2021/1399 of 24 August 2021 amending Regulation (EC) No 1881/2006 as regards maximum levels of ergot sclerotia and ergot alkaloids in certain foodstuffs (Text with EEA relevance)

  2. #2512284

    géardháileog thagartha (ARfD) a leagan síos, i gcás inarb ábhartha, do dhaoine;

    establish, where relevant, an acute reference dose (ARfD) for humans;

    Commission Regulation (EU) 2022/1439 of 31 August 2022 amending Regulation (EU) No 283/2013 as regards the information to be submitted for active substances and the specific data requirements for micro-organisms (Text with EEA relevance)

  3. #307861

    Beidh san áireamh sna sainchomhaid a thíolactar de bhun Airteagal 7(1) an fhaisnéis is gá chun an Iontógáil Laethúil Inghlactha (ADI), Leibhéal Inghlactha i dtaca leis an Oibreoir a bheith faoi lé na Substainte (AOEL) agus an Ghéardháileog Thagartha (ARfD) a shuíomh más ábhartha.

    The dossiers submitted pursuant to Article 7(1) shall contain the information needed to establish, where relevant, Acceptable Daily Intake (ADI), Acceptable Operator Exposure Level (AOEL) and Acute Reference Dose (ARfD).

    Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC

  4. #2112946

    Thairis sin, tháinig an tÚdarás ar an gconclúid nach bhfuil gá le géardháileog thagartha a bhunú mar gheall ar phróifíl ghéarthocsaineachta íseal na substainte.

    Moreover, the Authority concluded that the establishment of an acute reference dose is not necessary due to the low acute toxicity profile of the substance.

    Commission Regulation (EU) 2021/1247 of 29 July 2021 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for mandestrobin in grapes and strawberries (Text with EEA relevance)

  5. #2122445

    Bhunaigh sé géardháileog thagartha ghrúpa ina bhfuil 1 μg/kg de mheáchan coirp (b.w.) agus iontógáil laethúil infhulaingthe ghrúpa ina bhfuil 0,6 μg/kg b.w. in aghaidh an lae.

    It established a group acute reference dose of 1 μg/kg body weight (b.w.) and a group tolerable daily intake of 0,6 μg/kg b.w. per day.

    Commission Regulation (EU) 2021/1399 of 24 August 2021 amending Regulation (EC) No 1881/2006 as regards maximum levels of ergot sclerotia and ergot alkaloids in certain foodstuffs (Text with EEA relevance)

  6. #2122847

    Shocraigh an tÚdarás géardháileog thagartha ghrúpa (“ARfD”) arb é atá inti 0,016 μg/kg den mheáchan choirp (“b.w.”) arna sloinneadh mar shuim an (-)-hióisciaimín agus an (-)-scópolaimín, ag glacadh leis go bhfuil neart coibhéasach ann.

    The Authority established a group acute reference dose (‘ARfD’) of 0.016 μg/kg per body weight (‘b.w.’) expressed as the sum of (-)-hyoscyamine and (-)-scopolamine, assuming equivalent potency.

    Commission Regulation (EU) 2021/1408 of 27 August 2021 amending Regulation (EC) No 1881/2006 as regards maximum levels of tropane alkaloids in certain foodstuffs (Text with EEA relevance)

  7. #2139645

    Thairis sin, tháinig an tÚdarás ar an gconclúid nach bhfuil gá le géardháileog thagartha a bhunú ar bhonn phróifíl ghéarthocsaineachta íseal na substainte gníomhaí.

    Moreover, the Authority concluded that the establishment of an acute reference dose is not necessary on the basis of the low acute toxicity profile of the active substance.

    Commission Regulation (EU) 2021/1810 of 14 October 2021 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards the maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries (Text with EEA relevance)

  8. #2144869

    Thairis sin, tháinig an tÚdarás ar an gconclúid nach bhfuil gá le géardháileog thagartha a bhunú mar gheall ar phróifíl ghéarthocsaineachta íseal na substainte.

    Moreover, the Authority concluded that the establishment of an acute reference dose is not necessary due to the low acute toxicity profile of the substance.

    Commission Regulation (EU) 2021/1884 of 27 October 2021 amending Annex III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chlorantraniliprole in pulses (Text with EEA relevance)

  9. #2480919

    Thairis sin, tháinig an tÚdarás ar an gconclúid nach bhfuil gá le géardháileog thagartha a bhunú ar bhonn phróifíl ghéarthocsaineachta íseal na substainte gníomhaí.

    Moreover, the Authority concluded that the establishment of an acute reference dose is not necessary on the basis of the low acute toxicity profile of the active substance.

    Commission Regulation (EU) 2022/1264 of 20 July 2022 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fludioxonil in or on certain products (Text with EEA relevance)

  10. #2495139

    Tháinig an tÚdarás ar an gconclúid nár cheart go mbeadh éifeachtaí díobhálacha géara ag nochtadh an duine faoi bhun na géardháileoige tagartha (ARfD) 20 μg ciainíd/kg meáchan coirp (bw).

    The Authority concluded that a human exposure below the acute reference dose (ARfD) of 20 μg cyanide/kg body weight (bw) should not produce acute adverse effects.

    Commission Regulation (EU) 2022/1364 of 4 August 2022 amending Regulation (EC) No 1881/2006 as regards maximum levels of hydrocyanic acid in certain foodstuffs (Text with EEA relevance)

  11. #2503500

    Shocraigh an tÚdarás an ghéardháileog thagartha (ARfD) arb é atá inti 1 μg Δ9-THC/kg de mheáchan coirp (bw).

    The Authority established an acute reference dose (ARfD) of 1 μg Δ9-THC/kg body weight (bw).

    Commission Regulation (EU) 2022/1393 of 11 August 2022 amending Regulation (EC) No 1881/2006 as regards maximum levels of delta-9-tetrahydrocannabinol (?9-THC) in hemp seeds and products derived therefrom (Text with EEA relevance)

  12. #2712683

    Mhol an tÚdarás, ar bhonn na staidéar ar néarthocsaineacht fhorbarthach, gur cheart iontógáil laethúil inghlactha níos ísle (ADI) agus géardháileog thagartha (ARfD) níos ísle a leagan síos.

    The Authority proposed, based on the developmental neurotoxicity studies, that a lower acceptable daily intake (ADI) and acute reference dose (ARfD) should be established.

    Commission Regulation (EU) 2023/198 of 30 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin in or on certain products (Text with EEA relevance)

  13. #2743254

    Thairis sin, tugadh le fios sa réamh-mheasúnú ar ghéar-riosca cothútháin i gcás tomhaltóirí gur sáraíodh go mór an ghéardháileog thagartha le haghaidh na n-úsáidí ionadaíocha uile maidir leis na barra inite uile.

    Furthermore, the preliminary acute consumer dietary risk assessment indicated a large exceedance of the acute reference dose (‘ARfD‘) for all the representative uses on all edible crops.

    Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

  14. #516112

    (c) tá an iontógáil laethúil inghlactha a bhaineann léi, a géardháileog thagartha, nó a leibhéal inghlactha risíochta i gcás oibreoirí, de réir mar is iomchuí, níos ísle go mór ná an iontógáil laethúil inghlactha, an ghéardháileog thagartha nó an leibhéal inghlactha risíochta i gcás oibreoirí a bhaineann le formhór na substaintí gníomhacha maidir leis an gcineál céanna táirge agus maidir leis an gcás céanna úsáide;

    (c) its acceptable daily intake, acute reference dose or acceptable operator exposure level, as appropriate, is significantly lower than those of the majority of approved active substances for the same product-type and use scenario;

    Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products Text with EEA relevance

  15. #1920853

    Le teagmháil ar feadh an tsaoil le clórprófam trí chaitheamh na dtáirgí bia go léir a d’fhéadfadh é a bheith iontu, agus le nochtadh gearrthéarmach do chlórprófam agus a mhór-mheitibilít 3-clóranailín, trí go leor prátaí a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to chlorpropham via consumption of all food products that may contain it, nor the short-term exposure to chlorpropham and its major metabolite 3-chloroaniline, due to high consumption of potatoes, showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/155 of 9 February 2021 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for carbon tetrachloride, chlorothalonil, chlorpropham, dimethoate, ethoprophos, fenamidone, methiocarb, omethoate, propiconazole and pymetrozine in or on certain products (Text with EEA relevance)

  16. #2015885

    Le teagmháil ar feadh an tsaoil leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh iad a bheith iontu, agus le teagmháil ghearrthéarmach i ngeall ar go leor de na táirgí ábhartha sin a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/590 of 12 April 2021 amending Annexes II and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, boscalid, cow milk, etofenprox, ferric pyrophosphate, L-cysteine, lambda-cyhalothrin, maleic hydrazide, mefentrifluconazole, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate and triclopyr in or on certain products (Text with EEA relevance)

  17. #2029627

    Le teagmháil ar feadh an tsaoil leis na substaintí seo trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus le teagmháil ghearrthéarmach i ngeall ar go leor de na táirgí ábhartha sin a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/644 of 15 April 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fluxapyroxad, hymexazol, metamitron, penflufen and spirotetramat in or on certain products (Text with EEA relevance)

  18. #2031246

    Le teagmháil ar feadh an tsaoil agus le teagmháil ghearrthéarmach i ngeall ar go leor de na táirgí ábhartha sin a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/663 of 22 April 2021 amending Annex III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chlordecone in or on certain products (Text with EEA relevance)

  19. #2076736

    Le teagmháil ar feadh an tsaoil leis na substaintí seo trí chaitheamh na dtáirgí bia go léir a d’fhéadfadh iad a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí ábhartha a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/976 of 4 June 2021 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cycloxydim, mepiquat, Metschnikowia fructicola strain NRRL Y-27328 and prohexadione in or on certain products (Text with EEA relevance)

  20. #2090704

    Léiríodh nach baol do dhuine an iontógáil laethúil inghlactha a shárú, ná an ghéardháileog thagartha a shárú, de bharr ceachtar den dá rud seo: teagmháil ar feadh a shaoil leis na substaintí sin, ná caitheamh na dtáirgí bia go léir bhféadfaidís a bheith iontu.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/1098 of 2 July 2021 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 24-epibrassinolide, Allium cepa L. bulb extract, cyflumetofen, fludioxonil, fluroxypyr, sodium 5-nitroguaiacolate, sodium o-nitrophenolate and sodium p-nitrophenolate in or on certain products (Text with EEA relevance)

  21. #2128887

    Le teagmháil ar feadh an tsaoil leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a d’fhéadfadh iad a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí ábhartha a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/1531 of 17 September 2021 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, ethirimol, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products (Text with EEA relevance)

  22. #2137936

    Le teagmháil ar feadh an tsaoil leis an tsubstaint trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor piseanna a bhfuil faighneoga orthu a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to the substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of peas with pods showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/1804 of 12 October 2021 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards the maximum residue level for bentazone in peas with pods (Text with EEA relevance)

  23. #2138973

    Léiríodh nach baol iad an teagmháil ar feadh an tsaoil leis na substaintí sin de bharr chaitheamh na dtáirgí bia a bhféadfaidís a bheith iontu, ná teagmháil ghearrthéarmach de bharr ráta ard caithimh na dtáirgí ábhartha, nach baol iad go sárófaí an iontógáil laethúil inghlactha, ná an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/1807 of 13 October 2021 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acibenzolar-S-methyl, aqueous extract from the germinated seeds of sweet Lupinus albus, azoxystrobin, clopyralid, cyflufenamid, fludioxonil, fluopyram, fosetyl, metazachlor, oxathiapiprolin, tebufenozide and thiabendazole in or on certain products (Text with EEA relevance)

  24. #2143505

    Le teagmháil ar feadh an tsaoil leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2021/1842 of 20 October 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flupyradifurone and difluoroacetic acid in or on certain products (Text with EEA relevance)

  25. #2173243

    Dheimhnigh an tÚdarás an ghéardháileog thagartha (ARfD) ina bhfuil 10 μg moirfín/kg de mheáchan coirp (bw) agus chinn sé gur cheart tiúchan an chóidín sna samplaí de shíolta poipín a chur san áireamh trí chóidín a thiontú ina gcoibhéisí moirfín, trí úsáid a bhaint as fachtóir 0,2.

    The Authority confirmed the acute reference dose (ARfD) of 10 μg morphine/kg body weight (bw) and concluded that the concentration of codeine in the poppy seed samples should be taken into account by converting codeine to morphine equivalents, using a factor of 0,2.

    Commission Regulation (EU) 2021/2142 of 3 December 2021 amending Regulation (EC) No 1881/2006 as regards maximum levels of opium alkaloids in certain foodstuffs (Text with EEA relevance)

  26. #2285464

    Le teagmháil ar feadh an tsaoil leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to this substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2022/85 of 20 January 2022 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flonicamid in or on certain products (Text with EEA relevance)

  27. #2286251

    Le teagmháil ar feadh an tsaoil leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, léiríodh go bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed a risk of exceeding the acceptable daily intake or the acute reference dose.

    Commission Regulation (EU) 2022/93 of 20 January 2022 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acrinathrin, fluvalinate, folpet, fosetyl, isofetamid, ‘Pepino Mosaic Virus, EU strain, mild isolate Abp1’, ‘Pepino Mosaic Virus, CH2 strain, mild isolate Abp2’, spinetoram and spirotetramat in or on certain products (Text with EEA relevance)

  28. #2340275

    Léiríodh nach baol do dhuine an iontógáil laethúil inghlactha a shárú, ná an ghéardháileog thagartha a shárú, de bharr ceachtar den dá rud seo: teagmháil ar feadh a shaoil leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfaidís a bheith iontu, ná teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2022/476 of 24 March 2022 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetic acid, azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, emamectin, flutolanil, lime sulphur, maltodextrin and proquinazid in or on certain products (Text with EEA relevance)

  29. #2485407

    Léiríodh nach baol do dhuine an iontógáil laethúil inghlactha a shárú, ná an ghéardháileog thagartha a shárú, de bharr ceachtar den dá rud seo: teagmháil ar feadh a shaoil leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfaidís a bheith iontu, ná teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh.

    Neither the lifetime exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2022/1290 of 22 July 2022 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, chlormequat, dodine, nicotine, profenofos and Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV) isolate BV-0004 in or on certain products (Text with EEA relevance)

  30. #2506633

    I gcás meatocsaifeinisíde, i gcomhthéacs an nós imeachta chun formheas na substainte gníomhaí sin a athnuachan i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle, d’fhoilsigh an tÚdarás Eorpach um Shábháilteacht Bia (“an tÚdarás”) conclúid maidir leis an athbhreithniú piaraí ar an measúnú riosca ar an tsubstaint ghníomhach sin, lena ndeimhnítear an iontógáil laethúil inghlactha (ILI) atá ann cheana agus lena mbunaítear géardháileog thagartha níos ísle (ARfD).

    For methoxyfenozide, in the context of the procedure for the renewal of the approval of that active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, the European Food Safety Authority (‘the Authority’) published a conclusion on the peer review of the risk assessment of that active substance, confirming the existing acceptable daily intake (ADI) and establishing a lower acute reference dose (ARfD).

    Commission Regulation (EU) 2022/1406 of 3 August 2022 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for methoxyfenozide, propoxur, spinosad and thiram in or on certain products (Text with EEA relevance)

  31. #2706287

    Le teagmháil ar feadh an tsaoil leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to this substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/127 of 18 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl in or on certain products (Text with EEA relevance)

  32. #2707088

    Maidir le teagmháil fhadtéarmach leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the long-term exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/129 of 18 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, prosulfocarb, sedaxane and valifenalate in or on certain products (Text with EEA relevance)

  33. #2709929

    Maidir le teagmháil fhadtéarmach leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor den táirge lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sáraítear an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the long-term exposure to this substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant product showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/163 of 18 January 2023 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for DDT and oxathiapiprolin in or on certain products (Text with EEA relevance)

  34. #2712681

    Maidir le teagmháil ar feadh an tsaoil leis an tsubstaint trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sáraítear an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the lifetime exposure to the substance via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed that there is a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/198 of 30 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin in or on certain products (Text with EEA relevance)

  35. #2721151

    Maidir le teagmháil fhadtéarmach leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor den táirge lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sáraítear an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the long-term exposure to that substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/377 of 15 February 2023 amending Annexes II, III, IV and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzalkonium chloride (BAC), chlorpropham, didecyldimethylammonium chloride (DDAC), flutriafol, metazachlor, nicotine, profenofos, quizalofop-P, sodium aluminium silicate, thiabendazole and triadimenol in or on certain products (Text with EEA relevance)

  36. #2721179

    Maidir le teagmháil fhadtéarmach leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor den táirge lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sáraítear an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the long-term exposure to this substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/377 of 15 February 2023 amending Annexes II, III, IV and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzalkonium chloride (BAC), chlorpropham, didecyldimethylammonium chloride (DDAC), flutriafol, metazachlor, nicotine, profenofos, quizalofop-P, sodium aluminium silicate, thiabendazole and triadimenol in or on certain products (Text with EEA relevance)

  37. #2721621

    Maidir le flutríafól i nguird a bhfuil craiceann do-ite acu, is iomchuí an MRL a leagan síos ag an leibhéal a shainaithin an tÚdarás.

    The Authority concluded that all requirements with respect to completeness of data submission were met and that the modification to the MRLs requested by the applicant was acceptable with regard to consumer safety on the basis of a consumer exposure assessment for 27 specific European consumer groups. In so concluding, the Authority took into account the most recent data on the toxicological properties of the substances. Neither the long-term exposure to the substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/377 of 15 February 2023 amending Annexes II, III, IV and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzalkonium chloride (BAC), chlorpropham, didecyldimethylammonium chloride (DDAC), flutriafol, metazachlor, nicotine, profenofos, quizalofop-P, sodium aluminium silicate, thiabendazole and triadimenol in or on certain products (Text with EEA relevance)

  38. #2736326

    Maidir le teagmháil fhadtéarmach leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the long-term exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/679 of 23 March 2023 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for pyridaben, pyridate, pyriproxyfen and triclopyr in or on certain products (Text with EEA relevance)

  39. #2828085

    Maidir le teagmháil fhadtéarmach leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor den táirge lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sáraítear an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the long-term exposure to this substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/1042 of 26 May 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for folpet in or on certain products (Text with EEA relevance)

  40. #2828457

    Maidir le teagmháil fhadtéarmach leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the long-term exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/1049 of 30 May 2023 amending Annexes II and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fish oil, pendimethalin, sheep fat and spirotetramat in or on certain products (Text with EEA relevance)

  41. #2829880

    Maidir le teagmháil fhadtéarmach leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor den táirge lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sáraítear an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the long-term exposure to this substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/1068 of 1 June 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyantraniliprole in or on certain products (Text with EEA relevance)

  42. #2960828

    Maidir le teagmháil fhadtéarmach leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, níor léiríodh baol i leith ceachtar acu sin go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the long-term exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/1719 of 8 September 2023 amending Annexes II and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for isoxaben, metaldehyde, Metarhizium brunneum strain Ma 43, paclobutrazol and Straight Chain Lepidopteran Pheromones (SCLP) in or on certain products (Text with EEA relevance)

  43. #3206736

    I gcomhthéacs an nós imeachta chun formheas na substainte gníomhaí sin a athnuachan i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle, d’fhoilsigh an tÚdarás Eorpach um Shábháilteacht Bia (‘an tÚdarás’) conclúid maidir leis an athbhreithniú piaraí ar an measúnú riosca ar an tsubstaint ghníomhach sin, lena mbunaítear iontógáil laethúil inghlactha (ILI) níos ísle agus géardháileog thagartha níos ísle (ARfD).

    In the context of the procedure for the renewal of the approval of that active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, the European Food Safety Authority (‘the Authority’) published a conclusion on the peer review of the risk assessment of that active substance, establishing a lower acceptable daily intake (ADI) and a lower acute reference dose (ARfD).

    Commission Regulation (EU) 2024/331 of 19 January 2024 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for oxamyl in or on certain products

  44. #3207841

    Maidir le teagmháil fhadtéarmach leis na substaintí sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh siad a bheith iontu, agus maidir le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, ní léirítear baol i leith ceachtar acu sin go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the long-term exposure to these substances via consumption of all food products that may contain them nor the short-term exposure due to high consumption of relevant products show a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2024/342 of 22 January 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyflumetofen, oxathiapiprolin and pyraclostrobin in or on certain products

  45. #3208229

    Le teagmháil ar feadh an tsaoil leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha ná an ghéardháileog thagartha.

    Neither the lifetime exposure to this substance via consumption of all food products that may contain it nor the short-term exposure due to high consumption of the relevant products show a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2024/347 of 22 January 2024 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fipronil in or on certain products

  46. #3211004

    I gcomhthéacs an nós imeachta chun formheas na substainte gníomhaí iondocsacarb a athnuachan i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle, d’fhoilsigh an tÚdarás Eorpach um Shábháilteacht Bia (‘an tÚdarás’) conclúid maidir leis an athbhreithniú piaraí ar an measúnú riosca ar an tsubstaint ghníomhach sin, lena mbunaítear iontógáil laethúil inghlactha (‘ADI’) níos ísle agus géardháileog thagartha níos ísle (ARfD).

    In the context of the procedure for the renewal of the approval of indoxacarb in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, the European Food Safety Authority (‘the Authority’) published a conclusion on the peer review of the risk assessment of that active substance, establishing a lower acceptable daily intake (‘ADI’) and a lower acute reference dose (‘ARfD’).

    Commission Regulation (EU) 2024/376 of 24 January 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for indoxacarb in or on certain products

  47. #3212300

    Tháinig an tÚdarás ar an gconclúid gur léiríodh nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha le teagmháil ar feadh an tsaoil leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, ná le teagmháil ghearrthéarmach trí go leor de na táirgí lena mbaineann a chaitheamh, .

    The Authority concluded that neither the lifetime exposure to the substance via consumption of all food products that may contain it, nor the short-term exposure due to high consumption of those products showed that there is any risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2024/398 of 29 January 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for haloxyfop in or on certain products

  48. #3214408

    Le teagmháil fhadtéarmach (ainsealach) leis an tsubstaint sin trí chaitheamh na dtáirgí bia go léir a bhféadfadh sí a bheith iontu, agus le teagmháil ghearrthéarmach(géar) trí go leor de na táirgí lena mbaineann a chaitheamh, léirítear nach bhfuil baol ann go sárófaí an iontógáil laethúil inghlactha nó an ghéardháileog thagartha.

    Neither the long-term (chronic) exposure to that substance via consumption of all food products that may contain it nor the short-term (acute) exposure due to high consumption of relevant products show that there is any risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2024/451 of 5 February 2024 amending Annex III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for nicotine in or on certain products

  49. #2721624

    Ar bhonn na tuairime réasúnaithe ón Údarás, agus na tosca ábhartha a liostaítear in Airteagal 14(2) de Rialachán (CE) Uimh. 396/2005 á gcur san áireamh, is iomchuí na MRLanna a mhodhnú faoi mar a leagtar amach san Iarscríbhinn a ghabhann leis an Rialachán seo.

    The Authority concluded that all requirements with respect to completeness of data submission were met and proposed, based on the available data, setting a lower MRL that is acceptable with regard to consumer safety on the basis of a consumer exposure assessment for 27 specific European consumer groups. In so concluding, the Authority took into account the most recent data on the toxicological properties of the substances. Neither the long-term exposure to these substances via consumption of all food products that may contain them, nor the short-term exposure due to high consumption of the relevant products showed a risk that the acceptable daily intake or the acute reference dose is exceeded.

    Commission Regulation (EU) 2023/377 of 15 February 2023 amending Annexes II, III, IV and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzalkonium chloride (BAC), chlorpropham, didecyldimethylammonium chloride (DDAC), flutriafol, metazachlor, nicotine, profenofos, quizalofop-P, sodium aluminium silicate, thiabendazole and triadimenol in or on certain products (Text with EEA relevance)